Evaluation of the clinical efficiency of tocilizumab versus rituximab therapy in patients with rheumatoid arthritis
Objective: to evaluate the clinical efficiency of tocilizumab (TCZ) versus rituximab (RTM) therapy using DAS 28, SDAI, and CDAI scores and to estimate remission rates using DAS 28 and the remission criteria proposed by the European League Against Rheumatism (EULAR) and the American College of Rheuma...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado em: |
IMA PRESS LLC
2012-08-01
|
| Colecção: | Научно-практическая ревматология |
| Assuntos: | |
| Acesso em linha: | https://rsp.mediar-press.net/rsp/article/view/1032 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|